Panacea Biotec has received an additional order from UNICEF to supply 40 million doses of its bivalent oral polio vaccine (bopv). The order is valued at around $5.20 million (approximately ₹44 crore) and is scheduled for delivery in the third quarter of 2025.

Background and Continuation

This new order builds on an earlier agreement made in December 2024, where the company was awarded a contract to deliver 115 million bopv doses. The long-term contract between Panacea Biotec and UNICEF will be updated to include this new supply.

Key Details of the Order

The vaccines will be delivered internationally to meet UNICEF’s requirements. UNICEF will publicly share details about the supplier, vaccine type, contract duration and pricing on its official website. The full execution is planned for Q3 2025.

About the Companies 

Panacea Biotec is an Indian healthcare company that focuses on making vaccines, medicines and other health products. It has been involved in creating life-saving vaccines and has worked with global organisations to support public health. The company is known for its contribution to fighting diseases like polio and continues to grow through partnerships and international orders.

UNICEF (United Nations International Children’s Emergency Fund) is a global organisation that works to protect the health and well-being of children around the world. It provides vaccines, food, education and emergency help in different countries, especially in poor or crisis-affected areas. One of its main goals is to ensure every child gets the healthcare they need, including life-saving vaccines like the one ordered from Panacea Biotec.

Read More: Panacea Biotech Shares Fall 5% Despite Bombay HC Ruling Out 18% GST on Leasehold Land

Share Price Performance 

As of April 24, 2025, at 9:40 AM, Panacea Biotec share price is trading at ₹525.95 per share, reflecting a surge of 2.53% from the previous day’s closing price. Over the past month, the stock has surged by 19.06%. The stock’s 52-week high stands at ₹549.05 per share, while its low is ₹112.35 per share.

Conclusion

This new order highlights Panacea Biotec’s continued role in global health initiatives. The company remains committed to supporting international efforts like UNICEF’s polio vaccination program.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

On 23rd April 2025, NHPC Limited held a significant Board of Directors meeting to deliberate and decide on key infrastructural and financial matters. The spotlight was on renewable energy expansion and resource mobilisation, reflecting NHPC’s strategy to support India’s green energy mission.

Approval of 1200 MW Solar Park in Jalaun

A major highlight of the meeting was the approval for developing a 1200 MW solar park in the Jalaun district of Uttar Pradesh. The project will be executed by Bundelkhand Saur Urja Limited (BSUL), a subsidiary of NHPC and a joint venture with the Uttar Pradesh New & Renewable Energy Development Agency. This initiative will be carried out under the Ministry of New and Renewable Energy’s (MNRE) Mode 8-UMREPP scheme. With an estimated project cost of ₹796.96 crore, NHPC is set to invest ₹239.09 crore in equity, marking a substantial step toward increasing solar capacity in northern India.

Financial and Corporate Governance Resolutions

In addition to the solar initiative, the Board approved the issuance of Unsecured, Redeemable, Taxable, Non-Convertible, Non-Cumulative AF-Series Bonds worth up to ₹2,000 crore via private placement. This bond issue is part of NHPC’s borrowing plan for the financial year 2025–26 and is intended to support operational and project-based funding needs.

The Board also recommended the appointment of M/s Akhil Rohatgi & Co., Company Secretaries, Delhi, as the secretarial auditor for the next five financial years. This proposal will be placed before shareholders in the upcoming Annual General Meeting. The firm brings extensive experience with both government and private sector organisations.

Read More: NHPC Share Price Rises Over Sector Despite Conflicting Long-Term Signals

NHPC Share Performance 

As of April 24, 2025, 9:50 AM, NHPC share price is trading at ₹90, reflecting a 0.40% decline from the previous closing price. Over the past month, the stock has surged by 7.64%.

Conclusion

The Board meeting highlighted NHPC’s dual focus on sustainable energy development and robust financial planning. With the greenlighting of a major solar project and funding strategies, the company reaffirms its role in driving India’s renewable energy agenda.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing

EFC Limited has secured a landmark interior turnkey fit-out contract worth ₹183 crores from a leading Indian multinational corporation. This achievement highlights the company’s commitment to excellence and strengthens its standing as a trusted leader in the design and build sector.

Significant Contract Acquisition Strengthens Market Presence

On 23rd April 2025, EFC Limited announced the acquisition of a major interior turnkey fit-out project valued at ₹183 crores. Awarded by a leading Indian MNC, the contract involves comprehensive end-to-end interior solutions. This development follows EFC’s successful completion of several large-scale projects for reputed organisations, demonstrating its expertise, precision, and innovative approach in the industry.

Mr Umesh Sahay, Managing Director of EFC (I) Limited, stated that the achievement reflects the enduring trust their clients place in them and reinforces their drive to consistently exceed expectations. The new project is expected to further bolster EFC’s leadership in the integrated interior design and build sector.

Excellence in Design and Build Solutions

EFC Limited’s design and build division blends innovation with craftsmanship, delivering outstanding and functional spaces tailored to each client’s unique requirements. From concept to completion, the team ensures seamless execution, combining creativity, technical expertise, and an unwavering focus on quality.

With an impressive portfolio of high-profile projects, EFC Limited continues to transform corporate environments across India. Its commitment to delivering distinctive, high-value workspaces has made it a preferred partner for companies seeking excellence in interior infrastructure.

Read More: EFC (I) Ltd and Pepperfry Forge Strategic Partnership to Transform Furniture and Logistics

EFC(I) Share Performance 

As of April 24, 2025, 9:30 AM, EFC(I) share price is trading at ₹295.10, reflecting a 1.93% decline from the previous closing price. Over the past month, the stock has surged by 21.92%.

Conclusion

EFC(I) Limited’s latest contract acquisition reflects its strong market position, deep expertise, and continued dedication to delivering top-tier interior turnkey solutions, further cementing its reputation in the design and build industry.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

In a significant development for Niva Bupa Health Insurance Company Limited, the Insurance Regulatory and Development Authority of India (IRDAI) has formally approved the re-appointment of Mr Krishnan Ramachandran as the Chief Executive Officer and Managing Director. This re-appointment will be effective from 1 May 2025 and continue until 30 April 2030.

Regulatory Approval and Process

According to the company’s communication dated 23 April 2025, the IRDAI granted its approval on 22 April 2025 at 18:23 hours, following the prior endorsement by Niva Bupa’s Board of Directors on 4 February and its shareholders on 28 March 2025. 

The appointment had been subject to regulatory clearance under Section 34A of the Insurance Act, 1938. Niva Bupa confirmed that the application was made in line with legal provisions and that the regulatory authority responded positively with no conditions, penalties, or restrictions.

As per the disclosure made under Regulation 30(13) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the approval does not entail any financial implications for the company and does not reflect any aberrations or non-compliances.

Company Statement and Further Action

In the official filing addressed to the National Stock Exchange of India and BSE Limited, Niva Bupa stated that the details of the re-appointment have been uploaded to the company’s website. Mr Rajat Sharma, Company Secretary and Compliance Officer, affirmed the accuracy and completeness of the submitted information. No further action has been deemed necessary by the company in light of the received communication from the IRDAI.

Read More: Niva Bupa Health Insurance Share Price Jump 22% in Two Sessions: A Look at Recent Developments.

Niva Bupa Share Performance

As of April 24, 2025, 9:50 AM, Niva Bupa share price is trading at ₹85.30, reflecting a 1.83% surge from the previous closing price. Over the past month, the stock has surged by 14.94%.

Conclusion

The re-appointment of Mr Krishnan Ramachandran as CEO & Managing Director has been formally validated by the regulatory authority, allowing Niva Bupa to continue its leadership continuity for the next five years. This decision reaffirms the company’s regulatory compliance and governance standards.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing

Adani Hydro Energy Five Ltd, a step-down subsidiary of Adani Green Energy Ltd., has entered into a power purchase agreement with Uttar Pradesh Power Corporation Limited (UPPCL). The agreement is for 1,250 megawatts of energy storage capacity from pumped hydro storage projects. It was signed on April 23, 2025, the company did not share any financial details about the deal.

As of 10:04 AM on April 24, 2025, Adani Green Energy share price was trading at ₹958.55, up 0.64% for the day, 1.73% higher over the past five days, but down 43.36% over the last six months.

Earlier Contract for Solar Supply

In March, another subsidiary, Adani Renewable Energy Holding Twelve Ltd, won a contract to supply 400 megawatts of solar power to UPPCL. This will be done over 25 years from a solar project in Rajasthan. The agreed tariff is ₹2.57 per unit (kWh).

Solar Projects in Rajasthan

Adani Group is developing two solar parks in Rajasthan:

• One in Bhadla, Jodhpur, with a capacity of 500 MW
• Another in Fatehgarh, Jaisalmer, with a planned capacity of 1,500 MW
  The Fatehgarh park will cover around 9,981 acres.

Annual Performance Update

For FY25, Adani Green Energy reported a 28% rise in energy sales, reaching 27,969 million units. Its total operational capacity grew to 14.2 gigawatts, which is a 30% increase from the previous year. Over the last five years, the company’s energy generation has grown at a compound annual rate of 45%.

Read More: Adani Green Energy Subsidiary Commences 250 MW Solar Project in Kadapa, Andhra Pradesh.

Conclusion

Adani Green’s recent agreements with UPPCL add to its ongoing projects in solar and energy storage, expanding its presence in Uttar Pradesh and Rajasthan.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Biocon Ltd has received board approval to raise up to ₹4,500 crore through the issue of securities. The company may use methods including qualified institutional placements (QIP), rights issues, preferential allotments, or private placements. The issuance can be done in one or more phases, depending on how the plan progresses.

As of 10:00 AM on April 24, 2025, Biocon share price was trading at ₹327.45, down 2.46%, with a 6.26% decline over the past month and a 13.07% gain over the past year.

Instruments Under Consideration

According to the filing, the fundraising could include a combination of equity shares, non-convertible debentures (NCDs), warrants, or other convertible or eligible securities. All proposed issuances are subject to necessary shareholder and regulatory approvals.

Authorised Capital to Be Increased

The board has also approved increasing the company’s authorised share capital from ₹625 crore to ₹700 crore. This involves raising the number of equity shares from 125 crore to 140 crore, each with a face value of ₹5. The amendment will be made to the capital clause in Biocon’s Memorandum of Association and will also require shareholder approval.

Biocon plans to conduct a postal ballot to seek shareholder approval for both the fundraising proposal and the change in authorised share capital.

Company Overview

Biocon Ltd is a pharmaceutical company based in Bengaluru. It manufactures generic active pharmaceutical ingredients (APIs) and biosimilars. The company operates in both domestic and international markets.

Read More: Biocon Share Price Rose Over 5% Intraday: Check Why?

Conclusion

Biocon’s board has cleared proposals for a fundraise and capital restructuring. Further steps will depend on the results of the shareholder ballot and any regulatory clearances required.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

NBCC (India) Limited has secured new work orders with a combined value of approximately ₹64.67 crore. The contracts involve infrastructure development work in Odisha, Telangana, and Delhi. All three projects were awarded as part of the company’s regular business activity.

As of 9:48 AM on April 24, 2025, NBCC share price was trading at ₹100.06, down 0.74% for the day, but up 17.22% over the past month and 8.44% over the past six months.

Project in Odisha

NBCC has been assigned a project by the Department of Higher Education, Government of Odisha. The scope includes planning, designing, and construction for various developmental works at Dhamnagar College, located in Bhadrak district. The contract value for this project stands at ₹16.97 crore, excluding GST.

Work at NALSAR, Hyderabad

In Telangana, NBCC will undertake infrastructure-related tasks for NALSAR University of Law in Hyderabad. The contract, valued at ₹18.05 crore, covers planning, designing, and execution of construction works on the university campus.

Hostel Construction in Delhi

The third project involves constructing a hostel block at the Sewa Bharti Vidya Mandir campus in Mandoli, Delhi. This project is valued at ₹29.65 crore, making it the largest among the three. NBCC will handle the planning, designing, and full execution of the construction work.

Read more:  NBCC Secures Two Work Orders Worth ₹658.43 Crore!

Contract Overview

Regulatory Disclosure

The company disclosed the details of these work orders through an official stock exchange filing dated April 23, 2025. NBCC stated that the information is available on its website under the announcements section.

Conclusion

The projects are part of NBCC’s ongoing assignments in the infrastructure sector and follow standard business procedures without any special conditions.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Shriram Properties Limited has acquired a land parcel measuring around five acres in Yelahanka, located in North Bengaluru. The estimated gross development value (GDV) of the project is between ₹200 crore and ₹250 crore.

As of 9:52 AM on April 24, 2025, Shriram Properties share price was trading at ₹83.88, down 1.14% for the day, up 13.38% over the past month, but down 21.12% in the last six months.

Project Details 

The company plans to develop a residential project on the site. It will feature a mix of row houses and villas. The project launch is scheduled for the second half of FY26 and the construction on the land is to take place over a three-year period. The project will be positioned in a micro-market that has seen infrastructure development and residential growth in recent years.

The area includes access to educational institutions and is part of a zone experiencing increased urban activity. Yelahanka has seen growing interest from developers due to its connectivity and residential demand.

Company Background

Shriram Properties is a listed real estate firm headquartered in Bengaluru. Its operations primarily focus on the mid-market and mid-premium residential segments. The company operates across several cities, including Bengaluru, Chennai, Kolkata, and more recently, Pune.

Past and Ongoing Projects

As of March 31, 2025, the company has delivered 48 projects with a total saleable area of 26.5 million square feet. Its current pipeline includes 37 projects with a total development potential of 37.1 million square feet. Of this, 20 million square feet is under ongoing construction.

Recent Developments

In October 2024, the company entered into a joint development agreement for a six acre mixed-use project in Pune. The estimated revenue potential from that project ranges between ₹700 crore and ₹750 crore.

Read more: Shriram Properties Facilitates ASK Fund’s Early Exit in Shriram Pristine Estates!

Conclusion

The Yelahanka acquisition is part of Shriram Properties’ broader land and project pipeline additions across its core markets.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.